Read-Gene S.A. (WSE:RDG)
Poland · Delayed Price · Currency is PLN 4.860
+0.180 (3.85%)
At close: Jul 24, 2026
Read-Gene Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 15.84 | 15.6 | 13.23 | 10.15 | 7.24 | 6.45 | |
Revenue Growth (YoY) | 8.73% | 17.93% | 30.38% | 40.13% | 12.21% | 6.21% |
Cost of Revenue | 0 | 1 | 0.89 | 0.02 | 0.01 | 0.01 |
Gross Profit | 15.84 | 14.6 | 12.34 | 10.13 | 7.23 | 6.44 |
Selling, General & Admin | 12.46 | 13.01 | 11.67 | 10.89 | 6.53 | 6.1 |
Depreciation & Amortization Expenses | 0.46 | 0.45 | 0.48 | 0.49 | 0.46 | 0.56 |
Other Operating Expenses | -0.07 | 0.07 | -0.07 | -0.1 | -0.13 | -0.97 |
Total Operating Expenses | 12.85 | 13.53 | 12.08 | 11.28 | 6.86 | 5.69 |
Operating Income | -0.08 | 0.35 | -0.39 | -1.27 | 0.29 | 0.11 |
Interest Income | 0 | - | - | 0 | 0 | 0 |
Interest Expense | -0.33 | - | - | -0.4 | -0.23 | -0.06 |
Other Non-Operating Income (Expense) | 0.07 | -0 | -0.01 | 0.05 | -0 | -0 |
Total Non-Operating Income (Expense) | -0.26 | -0 | -0.01 | -0.35 | -0.23 | -0.06 |
Pretax Income | -0.04 | 0.12 | -0.58 | -1.62 | 0.06 | 0.05 |
Provision for Income Taxes | 0.05 | 0.02 | 0.53 | -0.28 | -0.15 | - |
Net Income | -0.09 | 0.1 | -1.11 | -1.35 | 0.21 | 0.05 |
Net Income to Common | -0.04 | 0.1 | -1.11 | -1.35 | 0.21 | 0.05 |
Net Income Growth | - | - | - | - | 305.59% | -84.95% |
Shares Outstanding (Basic) | 12 | 12 | 12 | 12 | 12 | 12 |
Shares Outstanding (Diluted) | 12 | 12 | 12 | 12 | 12 | 12 |
Shares Change (YoY) | - | - | - | - | - | - |
EPS (Basic) | -0.00 | 0.06 | -0.11 | -0.14 | 0.02 | -0.01 |
EPS (Diluted) | -0.00 | 0.06 | -0.11 | -0.14 | 0.02 | -0.01 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | 0.1 | 0.21 | 2.43 | -0.46 | 0.36 | 0.17 |
Free Cash Flow Growth | -96.41% | -91.53% | - | - | 117.66% | -85.38% |
Free Cash Flow Per Share | 0.01 | 0.02 | 0.21 | -0.04 | 0.03 | 0.01 |
Gross Margin | 99.97% | 93.56% | 93.27% | 99.82% | 99.85% | 99.79% |
Operating Margin | -0.51% | 2.26% | -2.95% | -12.52% | 3.95% | 1.76% |
Profit Margin | -0.56% | 0.62% | -8.40% | -13.27% | 2.94% | 0.81% |
FCF Margin | 0.66% | 1.32% | 18.36% | -4.52% | 5.00% | 2.58% |
EBITDA | 0.38 | 0.81 | 0.09 | -0.78 | 0.74 | 0.67 |
EBITDA Margin | 2.41% | 5.16% | 0.69% | -7.66% | 10.25% | 10.43% |
EBIT | -0.08 | 0.35 | -0.39 | -1.27 | 0.29 | 0.11 |
EBIT Margin | -0.51% | 2.26% | -2.95% | -12.52% | 3.95% | 1.76% |
Effective Tax Rate | -130.72% | 15.98% | -92.73% | 17.09% | -250.81% | 0.00% |